{
  "docId": "019dd923-5ca1-7489-b637-cbc3d52595b6",
  "docSlug": "d6221ecb09fac4d1",
  "documentTitle": "Venture Pulse Q3 2024",
  "authorId": "KPMG",
  "authorName": "KPMG",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 20,
  "pageCount": 96,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": "KPMG Private Enterprise report slide.",
  "elementsJson": [
    "headline_text",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b637-cbc3d52595b6/20",
  "deckHref": "/decks/019dd923-5ca1-7489-b637-cbc3d52595b6",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b637-cbc3d52595b6.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b637-cbc3d52595b6#slide-20",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "VC investment in the US fell in Q3'24, driven in part by an expected seasonal slowdown in VC deals activity.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-c7c7-7483-83c5-00e41f7ea969",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.46,
        "x": 0.51,
        "y": 0.31
      },
      "kind": "list",
      "text": "CVC investment in US on pace to exceed 2023 total despite decline in deal volume. Corporate VC investment in the US remained relatively robust in Q3'24, particularly compared to the levels of CVC investment seen in other regions. Many corporates in the US continued to see CVC investing as a strategic move — a way to offset the need to make major internal R&D investments by investing in promising startups that they could potentially acquire in the future.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1213e076-1d0f-47f1-bb08-a2e427dce244",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.46,
        "x": 0.03,
        "y": 0.21
      },
      "kind": "list",
      "text": "Investor interest in AI remains red hot. Despite continued uncertainty in the market, AI continued to see incredibly strong VC investment in the US during Q3'24, led by a $1.5 billion raise by AI-powered defense solutions company Anduril Industries and a $1 billion raise by core AI-focused startup Safe Superintelligence. A wide range of other AI-focused startups also raised $100 million+ funding rounds during the quarter, including Gen AI-focused chip developer Groq ($640 million), immersive technologies company Infinite Reality ($350 million), data infrastructure company Cribl ($319 million), AI-focused surgical solutions company Caresyntax ($310 million), and airline retail platform Flyr ($295 million).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "655ae4d0-d2b0-4801-a07e-d1285dd0f1b4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.46,
        "x": 0.51,
        "y": 0.47
      },
      "kind": "list",
      "text": "Seed and angel stage investments decline as VC investors back away from riskier bets. At the end of Q3'24, seed and angel stage funding levels in the US were both well behind the pace needed to match even 2023's soft results. Given the slow exit environment, many VC investors in the US have become cautious with their early-stage investments, prioritizing investments in lower risk startups with proven value propositions and well-defined paths to profitability.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74424a90-2d46-4a95-a381-217a6cde25bb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.46,
        "x": 0.03,
        "y": 0.63
      },
      "kind": "list",
      "text": "IPO activity remains dry with a few exceptions — like biotech. IPO activity in the US remained quiet in Q3'24, with the exception of biotech — which saw some robust IPO activity late in the quarter, including companies like immunology focused Zenas Biopharma, oncology-focused Bicara Therapeutics, and precision peptide therapy company MBX Biosciences.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8dc9e87b-fda7-44b3-b709-0d5c3528cdd3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.46,
        "x": 0.03,
        "y": 0.47
      },
      "kind": "list",
      "text": "Due diligence continues to be a priority for VC investors in the US. Given the uncertain economic environment and the sustained lack of exit activity, VC investors continued to prioritize deal due diligence during Q3'24, taking a deeper look into areas like pathways to profitability, EBITA targets, growth expectations, and other indicators, prior to making major investment decisions.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa2717be-7b43-4ba3-a84f-e956ea8b06b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.11
      },
      "kind": "paragraph",
      "text": "VC investment in the US fell in Q3'24, driven in part by an expected seasonal slowdown in VC deals activity. Given the approaching presidential election, some US VC investors have also pulled back from making major investment decisions until the outcome of the election is known and the potential policy directions of the next president are better understood.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3fbe2f0-ff2c-430a-bdda-e3f916651d77",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.78,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "VC investment in the US dips slightly; AI continues to attract big tickets",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f48dc580-9928-4660-806f-e71751a0b257",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 20,
      "beatId": "da30c9ca-54fe-47bc-ac2d-0ec93a20c6b0",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Market size",
      "beatSlug": "sequoia-pitch-market-size",
      "evidence": "The report provides an analysis of market size, including data on VC investment in various regions and sectors.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}